Cargando…
Identification of Prognostic and Chemopredictive microRNAs for Non-Small-Cell Lung Cancer by Integrating SEER-Medicare Data
This study developed a novel methodology to correlate genome-scale microRNA (miRNA) expression profiles in a lung squamous cell carcinoma (LUSC) cohort (n = 57) with Surveillance, Epidemiology, and End Results (SEER)-Medicare LUSC patients (n = 33,897) as a function of composite tumor progression in...
Autores principales: | Ye, Qing, Putila, Joseph, Raese, Rebecca, Dong, Chunlin, Qian, Yong, Dowlati, Afshin, Guo, Nancy Lan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306800/ https://www.ncbi.nlm.nih.gov/pubmed/34299277 http://dx.doi.org/10.3390/ijms22147658 |
Ejemplares similares
-
MicroRNA-Based Discovery of Biomarkers, Therapeutic Targets, and Repositioning Drugs for Breast Cancer
por: Ye, Qing, et al.
Publicado: (2023) -
A Predictive 7-Gene Assay and Prognostic Protein Biomarkers for Non-small Cell Lung Cancer
por: Guo, Nancy Lan, et al.
Publicado: (2018) -
Analysis of Chemopredictive Assay for Targeting Cancer Stem Cells in Glioblastoma Patients
por: Howard, Candace M., et al.
Publicado: (2017) -
Quantification and expert evaluation of evidence for chemopredictive biomarkers to personalize cancer treatment
por: Rao, Shruti, et al.
Publicado: (2016) -
MicroRNA, mRNA, and Proteomics Biomarkers and Therapeutic Targets for Improving Lung Cancer Treatment Outcomes
por: Ye, Qing, et al.
Publicado: (2023)